Tilray Brands, Inc. (TLRY)

NASDAQ • Healthcare

$4.13

-$0.07 (-1.7%)

Market closed

September 10, 2026 at 20:00 UTC

Open$4.15

Day Range$4.1 - $4.26

Avg. Volume (3M)3.5M

Market Cap$462.9M

52 Week Range

$3.67$23.2

Next EarningsIn 28 daysOct 8, 2026

12H

All

22:26:19 UTC

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$281.7M100%

Gross Profitminus cost of goods$84.3M30%

In plain terms: out of every $100 in revenue, Tilray Brands, Inc. currently loses $18.

Fundamentals & Financials

Revenue (TTM)

$1.1B

Net Income (TTM)

-$149M

EPS (TTM)

-$1.33

ROA (TTM)

-6.4%

Current Ratio

2.21

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+185.1%Q3 2025$0.2

+98.5%Q4 2025$0

-192.9%Q1 2026-$0.41

-71.4%Q2 2026-$0.24

-3471.4%Q3 2026-$0.43

Oct 8

in 28 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -3471.4%

Tilray Brands’ preliminary fiscal fourth quarter of 2026, reported July 28, saw adjusted EPS of -$0.43 versus the -$0.01 estimate, a miss of about -3,471%. Based on preliminary results, gross profit came to about $26.2 million, operating income was negative about $42.8 million, and operating cash flow was negative about $37.3 million; revenue also came in 14.4% above consensus. Next-period consensus calls for EPS of -$0.14 on revenue of $251.2 million.

Next report — what to expect

Tilray Brands Inc (TLRY) reports on October 8, 2026. Wall Street expects EPS of -$0.166 on revenue of $269.4 million. For trailing context, revenue fell -8.6% year over year last quarter. Tilray has beaten EPS in 2 of 8 most recent quarters, so watch for margin and demand commentary alongside top-line results.

View full earnings history

About Tilray Brands, Inc.

Tilray Brands, Inc. (NASDAQ: TLRY) operates across cannabis, beverage alcohol, and wellness businesses within the healthcare sector, with FY2025 revenue of $1.1 billion. The company sells medical and adult-use cannabis products, pharmaceutical and wellness goods it procures for resale, alcoholic beverages, and hemp-derived food and other wellness items.

Name

Tilray Brands, Inc.

CEO

Irwin David Simon

Website

www.tilray.com

Industry

Healthcare

Year Founded

2013

Employees

3,595

Today's Snapshot

AI-generated

TLRY closed 1.7% lower at 4.14, in line with a weaker sector. Tilray Brands brought back its Shock Top wheat beer in a tailgate campaign with Auntie Anne’s, a pretzel chain.

Trading Volume

Below 10d avg (3.4M)

2.9M

vs S&P 500 Today

Underperforming Market

-1.09%

Updated: September 10, 2026 at 20:20 UTC

TLRY Headlines

Tilray to Acquire HelloMD’s Canada Assets

June 29, 2026

3 min read

Front-Side Shorts Crowd Into Avis Spike

April 9, 2026

1 min read

View All News

Technical Indicators

1 Buy1 Neutral6 Sell

TLRY’s technical picture supports a sell stance as momentum indicators and moving averages point to weakness while trend strength remains muted. The RSI sits in the mid-30s and the MACD level is slightly negative, signaling bearish momentum, and the stock trades below most short- and long-term averages including the 200‑day, which underscores longer-term pressure. Volume-based OBV is strongly negative and ATR shows modest relative volatility, while the pivot sits near current levels. Technical takeaway: Sell — weak trend and prevailing bearish momentum characterize the setup.

All signals